Cargando…

Citicoline for traumatic brain injury: a systematic review & meta-analysis

BACKGROUND: Traumatic Brain Injury (TBI) is the leading cause of mortality and morbidity especially in young ages. Despite over 30 years of using Neuroprotective agents for TBI management, there is no absolute recommended agent for the condition yet. METHODS: This study is a part of a scoping review...

Descripción completa

Detalles Bibliográficos
Autores principales: Meshkini, Ali, Meshkini, Mohammad, Sadeghi-Bazargani, Homayoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kermanshah University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279991/
https://www.ncbi.nlm.nih.gov/pubmed/28039682
http://dx.doi.org/10.5249/jivr.v9i1.843
_version_ 1782502876872966144
author Meshkini, Ali
Meshkini, Mohammad
Sadeghi-Bazargani, Homayoun
author_facet Meshkini, Ali
Meshkini, Mohammad
Sadeghi-Bazargani, Homayoun
author_sort Meshkini, Ali
collection PubMed
description BACKGROUND: Traumatic Brain Injury (TBI) is the leading cause of mortality and morbidity especially in young ages. Despite over 30 years of using Neuroprotective agents for TBI management, there is no absolute recommended agent for the condition yet. METHODS: This study is a part of a scoping review thesis on "Neuroprotective agents using for Traumatic Brain Injury: a systematic review & meta-analyses", which had a wide proposal keywords and ran in "Cochrane CENTRAL", "MedLine/PubMed", "SCOPUS", "Thomson Reuters Web of Science", "SID.ir", "Barket Foundation", and "clinicaltrials.gov" databases up to September 06, 2015. This study limits the retrieved search results only to those which used \citicoline for TBI management. The included Randomized Clinical Trials’ (RCTs) were assessed for their quality of reporting by adapting CONSORT-checklist prior to extracting their data into meta-analysis. Meta-analyses of this review were conducted by Glasgow Outcome Scale (GOS) in acute TBI patients and total neuropsychological assessments in both acute and chronic TBI management, mortalities and adverse-effects. RESULTS: Four RCTs were retrieved and included in this review with 1196 participants (10 were chronic TBI impaired patients); the analysis of 1128 patients for their favorable GOS outcomes in two studies showed no significant difference between the study groups; however, neuropsychological outcomes were significantly better in placebo/control group of 971 patients of three studies. Mortality rates and adverse-effects analysis based on two studies with 1429 patients showed no significant difference between the study groups. However, two other studies have neither mortality nor adverse effects reports due to their protocol. CONCLUSIONS: Citicoline use for acute TBI seems to have no field of support anymore, whereas it may have some benefits in improving the neuro-cognitive state in chronic TBI patients. It’s also recommended to keep in mind acute interventions like Psychological First Aid (PFA) during acute TBI management.
format Online
Article
Text
id pubmed-5279991
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Kermanshah University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-52799912017-03-13 Citicoline for traumatic brain injury: a systematic review & meta-analysis Meshkini, Ali Meshkini, Mohammad Sadeghi-Bazargani, Homayoun J Inj Violence Res Injury &Violence BACKGROUND: Traumatic Brain Injury (TBI) is the leading cause of mortality and morbidity especially in young ages. Despite over 30 years of using Neuroprotective agents for TBI management, there is no absolute recommended agent for the condition yet. METHODS: This study is a part of a scoping review thesis on "Neuroprotective agents using for Traumatic Brain Injury: a systematic review & meta-analyses", which had a wide proposal keywords and ran in "Cochrane CENTRAL", "MedLine/PubMed", "SCOPUS", "Thomson Reuters Web of Science", "SID.ir", "Barket Foundation", and "clinicaltrials.gov" databases up to September 06, 2015. This study limits the retrieved search results only to those which used \citicoline for TBI management. The included Randomized Clinical Trials’ (RCTs) were assessed for their quality of reporting by adapting CONSORT-checklist prior to extracting their data into meta-analysis. Meta-analyses of this review were conducted by Glasgow Outcome Scale (GOS) in acute TBI patients and total neuropsychological assessments in both acute and chronic TBI management, mortalities and adverse-effects. RESULTS: Four RCTs were retrieved and included in this review with 1196 participants (10 were chronic TBI impaired patients); the analysis of 1128 patients for their favorable GOS outcomes in two studies showed no significant difference between the study groups; however, neuropsychological outcomes were significantly better in placebo/control group of 971 patients of three studies. Mortality rates and adverse-effects analysis based on two studies with 1429 patients showed no significant difference between the study groups. However, two other studies have neither mortality nor adverse effects reports due to their protocol. CONCLUSIONS: Citicoline use for acute TBI seems to have no field of support anymore, whereas it may have some benefits in improving the neuro-cognitive state in chronic TBI patients. It’s also recommended to keep in mind acute interventions like Psychological First Aid (PFA) during acute TBI management. Kermanshah University of Medical Sciences 2017-01 /pmc/articles/PMC5279991/ /pubmed/28039682 http://dx.doi.org/10.5249/jivr.v9i1.843 Text en Copyright © 2017, KUMS http://creativecommons.org/licenses/by/3/ This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Injury &Violence
Meshkini, Ali
Meshkini, Mohammad
Sadeghi-Bazargani, Homayoun
Citicoline for traumatic brain injury: a systematic review & meta-analysis
title Citicoline for traumatic brain injury: a systematic review & meta-analysis
title_full Citicoline for traumatic brain injury: a systematic review & meta-analysis
title_fullStr Citicoline for traumatic brain injury: a systematic review & meta-analysis
title_full_unstemmed Citicoline for traumatic brain injury: a systematic review & meta-analysis
title_short Citicoline for traumatic brain injury: a systematic review & meta-analysis
title_sort citicoline for traumatic brain injury: a systematic review & meta-analysis
topic Injury &Violence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279991/
https://www.ncbi.nlm.nih.gov/pubmed/28039682
http://dx.doi.org/10.5249/jivr.v9i1.843
work_keys_str_mv AT meshkiniali citicolinefortraumaticbraininjuryasystematicreviewmetaanalysis
AT meshkinimohammad citicolinefortraumaticbraininjuryasystematicreviewmetaanalysis
AT sadeghibazarganihomayoun citicolinefortraumaticbraininjuryasystematicreviewmetaanalysis